Director/PDMR Shareholding

RNS Number : 1567K
Physiomics PLC
06 April 2018
 

Physiomics plc

("Physiomics") or ("the Company")

 

Director Dealing

 

The Company announces that it received notice today that Dr Chassagnole (COO) transferred paper share certificates of 121,522 shares and 265,111 shares to his nominee account 'Interactive Investor Services Nominees Limited'.

 

Following the transfer of shares, Dr Chassagnole's beneficial holding remains unchanged at 417,008 ordinary shares (equivalent to 0.71% of the currently issued share capital).

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Christophe Chassagnole

2

Reason for the notification

a)

Position/status

Director, COO

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Physiomics plc

b)

LEI

213800A71DSZ6ABMTQ91

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

 

Identification code

Transfer of securities held in paper share certificates to nominee account 'Interactive Investor Services Nominees Limited'

 

GB00BDR6W943

b)

Nature of the transaction

Trans

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

N/A

121,522

265,111

d)

Aggregated information

-     Aggregated volume

-     Price

 

386,663

N/A

e)

Date of the transaction

05/04/2018

f)

Place of the transaction

XOFF

 

 

Enquiries:

 

Physiomics plc                                                  

Dr Jim Millen, CEO

+44 (0)1865 784 980

 

WH Ireland Limited (nomad)

Katy Mitchell, James Sinclair-Ford

+44 (0) 161 832 2174

 

Hybridan LLP (broker)

Claire Louise Noyce

+44 (0) 203 764 2341

 

 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHIFMJTMBJMBLP

Companies

Physiomics (PYC)
UK 100

Latest directors dealings